# BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
> **ANDA207607** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN TECHNOLOGIES · Approved 2018-06-14
## Drug
- **FDA Application Number:** ANDA207607
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
- **Generic name:** BUPRENORPHINE AND NALOXONE
- **Active ingredients:** BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
- **Dosage form:** FILM
- **Route:** BUCCAL, SUBLINGUAL
- **Marketing status:** Prescription
- **Sponsor:** MYLAN TECHNOLOGIES
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2018-06-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207607)
---
*MORVS · CC0 1.0*